Meningococcal Infections
📧 Sign up to get email alerts when something new happens for Meningococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years [Phase 1, Phase 2]
Phase 1/2 exploratory trial assessing safety and immunogenicity of Menactra and Menomune in people aged 56 and older; results were posted in…
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune® [Phase 2]
Phase 2 trial assessing how long antibodies persist after a single dose of Menactra or Menomune in adolescents and adults aged 15 to 23.
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® [Phase 4]
Phase 4 clinical trial assesses safety and immunogenicity of intradermal versus subcutaneous dosing of Menomune for meningococcal infections…
-
CLINICAL_TRIALS trial_result · 2006-12-22Clinical Trial Update: Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 clinical trial of a fractional-dose tetravalent meningococcal polysaccharide vaccine (serogroups A, C, Y, W135) has completed.